AVM v1, released 02-OCT-22

A manually curated database of aerosol-transmitted virus mutations, human diseases, and drugs

Mutation detail:


Mutation site P453S
Virus Influenzavirus A H1N1
Mutation level Amino acid Level
Gene/protein/region type PB2
Gene ID 23308131
Country China
Mutation type nonsynonymous mutation
Genotype/subtype/clade -
Sample Human
Variants -
Viral reference sequence CY010795.1
Drug/antibody/vaccine -
Transmissibility -
Transmission mechanism -
Pathogenicity -
Pathogenicity mechanism -
Immune escape mutation -
Immune escape mechanism -
RT-PCR primers probes -

Protein detail:


Protein name Polymerase PB2
Uniprot protein ID C3W5X5
Protein length 759 amino acids
Protein description PB2 plays an essential role in transcription initiation and cap-stealing mechanism, in which cellular capped pre-mRNAs are used to generate primers for viral transcription. Recognizes and binds the 7-methylguanosine-containing cap of the target pre-RNA which is subsequently cleaved after 10-13 nucleotides by the viral protein PA. Plays a role in the initiation of the viral genome replication and modulates the activity of the ribonucleoprotein (RNP) complex.

Literature information:


Pubmed ID 21483816
Clinical information No
Disease -
Published year 2011
Journal PLoS One
Title Reassortment and mutations associated with emergence and spread of oseltamivir-resistant seasonal influenza A/H1N1 viruses in 2005-2015
Author Ji-Rong Yang,Yu-Cheng Lin,Yuan-Pin Huang,Chun-Hui Su,Je Lo
Evidence The dominant variant acquired additional substitutions, including A206T in HA, H275Y and D354G in NA, L30R and H41P in PB1-F2, and V411I and P453S in basic polymerase 2 (PB2) proteins and subsequently caused the 2008-2014 influenza epidemic in Taiwan, accompanying the widespread oseltamivir-resistant viruses.